Dr. Yun Wang, MD

Dr. Wang practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Wang's NPI, 1629422977, was assigned on April 22, 2016. Dr. Wang graduated from College of Human Medicine - Grand Rapids in 2016. Dr. Wang's California license number on file is A152013.

Dr. Wang's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Wang's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Wang is also affiliated with Torrance Memorial Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Wang to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 4 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Wang is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Wang's licenses on file in 2 states: California and Michigan.

Dmand AI lists cirrhosis of the liver, fatty liver and hepatitis c among the conditions Dr. Wang treats.

CMS data shows 451 Medicare services from Dr. Wang across 7 procedure codes in 2024, for 258 Medicare patients. Medicare paid $45,945 for them.

CMS counts 258 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 63, with 54% women.

In 2024, Dr. Wang wrote 292 Medicare Part D claims for 70 patients. 64% of them were for generic drugs. CMS names the drug for 216 of them, across 7 drugs with 11 or more claims each, at $193,569 in total drug cost. In 2023, CMS named 41 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Wang, published from 2019 to 2025. 2024 was the busiest year, with 2. Dr. Wang's most frequent co-authors are Walid S. Ayoub, MD, Steven-Huy Bui Han, MD and Alexander Kuo, MD.

CMS Open Payments shows 5 general payments to Dr. Wang from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $321.

Dr. Wang graduated from College of Human Medicine - Grand Rapids in 2016. Dr. Wang is a member of American Association for the Study of Liver Diseases (AASLD) and AGA.

Dr. Wang is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.